Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 3Terminated 2Recruiting 2Unknown 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Colorectal Neoplasms 13Carcinoma, Hepatocellular 7Neoplasms 3Liver Neoplasms 2Glioblastoma 2Gastrointestinal Stromal Tumors 2Colonic Neoplasms 2Uterine Cervical Neoplasms 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Recurrence 1Rectal Neoplasms 1Piebaldism 1Patient Compliance 1Pathologic Complete Response 1Ovarian Neoplasms 1Osteosarcoma 1Neoplasm Metastasis 1Multiple Myeloma 1Microsatellite Stable Metastatic Colorectal Cancer 1Meningioma 1Melanoma 1MCRC 1Lymphoma, Non-Hodgkin 1Lung Neoplasms 1Liver Metastases 1Leiomyosarcoma 1

Interventions

Bevacizumab 9pembrolizumab 5lenvatinib 5durvalumab 5atezolizumab 5tremelimumab 3fludarabine 3camrelizumab 3apatinib 3Ipilimumab 3Cyclophosphamide 3regorafenib 2Riluzole 2Radiotherapy 2Nivolumab 2Magnetic Resonance Imaging 2Idarubicin 2Blood Specimen Collection 2Biopsy 2yttrium chloride 1trastuzumab deruxtecan 1spartalizumab 1sintilimab 1pertuzumab 1ferric carboxymaltose 1epigallocatechin gallate 1donafenib 1cemiplimab 1brodalumab 1Yttrium-90 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Liver Neoplasms × regorafenib × Clear all
NCT05155189 2026-01-21

A Study to Evaluate Safety and Efficacy of Armored CAR-T Cell Injection C-CAR031 in Advanced Hepatocellular Carcinoma

Zhejiang University

Phase 1 Recruiting
72 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT05713994 2025-03-25

CCGLC-001

Tongji Hospital

Recruiting
300 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡